| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3584 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172 |
| filingDate |
2017-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108697880-B |
| titleOfInvention |
Visualization and Analysis Tools for Drug Delivery Systems |
| abstract |
Provided is a visualization and analysis tool for an insulin delivery system, such as an artificial pancreas, in which insulin is delivered using a patient-controllable pump based on a system algorithm for adjusting insulin relative to a baseline delivery rate Delivery; eg default basal rate and sensors for measuring glucose levels. The tool is configured with the controller of the system to detect and record events based on the difference between the actual insulin delivered by the system and the baseline delivery rate. These detected events are measurements that provide information related to the therapeutic value of the system (in the absence of such measurements, the therapeutic value of the system may be overlooked or unnoticed), thereby fostering trust and confidence. In addition, information is provided that further improved glucose control can be achieved. |
| priorityDate |
2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |